Therapeutic/cosmetic compositions comprising CGRP antagonists fo

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds hormone or other secreted growth regulatory factor,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241301, 4241331, 4241451, 4241851, 4241981, 424809, 424401, 514 2, A61K 39395, A61K 3900, A61K 600, A01N 3718

Patent

active

059322152

ABSTRACT:
Skin redness, rosacea and/or discreet erythema afflicting a mammalian, notably human patient, are therapeutically treated by administrating to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist.

REFERENCES:
patent: 5164372 (1992-11-01), Matsuo et al.
patent: 5445823 (1995-08-01), Hall et al.
patent: 5585385 (1996-12-01), Natsugari et al.
patent: 5658581 (1997-08-01), Lacharriere et al.
patent: 5679360 (1997-10-01), Lacharriere et al.
patent: 5730998 (1998-03-01), Lacharriere et al.
patent: 5744156 (1998-04-01), Lacharriere et al.
patent: 5824650 (1998-10-01), Lacharriere et al.
patent: 5869068 (1999-02-01), Lacharriere et al.
Bartho et al. 1991 Neuroscience Letters 129 pp. 156-159, Jan. 1, 1991.
Brain et al 1986 J Invest Dermatol 87 pp. 533-536, Jan. 1, 1986.
Fuller et al. 1987 Br J Pharmacol 92 pp. 781-788, Jan. 1, 1987.
Herbert et al. 1994 Br J Pharmacol 111 pp. 681-686, Jan. 1, 1994.
Hua et al. 1993 J Neurosci 13 (5) pp. 1947-53, May 1, 1993.
Peskar et al. 1993 Eur J Pharmacology 250 pp. 201-203, Jan. 1, 1993.
Shaw et al. 1992 Br J Pharmacol 106 pp. 196-198, Jan. 1, 1992.
Tan et al. 1995 Clinical Science 89 pp. 565-5733, Dec. 1, 1995.
Wallengren et al. 1987 Eur J Pharmacol 143 pp. 267-273, Nov. 10, 1987.
Neuroscience, vol. 48, No. 4, Jun. 1992, pp. 963-968, T.L. Buckley, et al., `The Partial Inhibition of Inflammatory Responses Induced by a Capsaicin Using the Fab Fragment of a Selective Calcitonin Gene-Related Peptide Antiserum in Rabbit Skin.`
British Journal of Pharmacology, vol. 110, No. 2, 1993, pp. 772-776, K. Jane Escott, et al., `Effect of Calcitonin Gene-Related Peptide Antagonist (CGRP 8-37) on Skin Vasodilatation and Oedema Induced by Stimulation of the Rat Saphenous Nerve.`
British Journal of Pharmacology, vol. 104, No. 3, Nov. 1991, pp. 738-742, S.R. Hughes, et al., `A Calcitonin Gene-Related Peptide (CGRP) Antagonist (CGRP 8-37) Inhibits Microvascular Responses Induced by CGRP and Capsaicin in Skin.`
Neuroscience Letters, vol. 102, No. 2.3, Jul. 31, 1989, pp. 257-260, S.M. Louis, et al., `Antibodies to Calcitonin Gene-Related Peptide Reduce Inflammation Induced by Topical Mustard Oil But Not That Due to Carrageenin in the Rat.`

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic/cosmetic compositions comprising CGRP antagonists fo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic/cosmetic compositions comprising CGRP antagonists fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic/cosmetic compositions comprising CGRP antagonists fo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-847428

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.